Clinical Trial Update: SQ-Kyrin-T First-in-man Feasibility Study [NA]

View source ↗

Summary

A first-in-man feasibility study of SQ-Kyrin-T for tricuspid regurgitation is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Regurgitation

Drugs mentioned

• SQ-Kyrin-T

Snippet

Sponsor: Shanghai Shenqi Medical Technology Co., Ltd | Conditions: Tricuspid Regurgitation | NA | Status: ACTIVE_NOT_RECRUITING